tirzepatide trial cuts risk of diabetes by 94% in adults with prediabetes and obesity or overweight, drugmaker says Tirzepatide for Obesity Treatment and

The first month was hard on my stomach, not going to lie

Learn about Semaglutide (Ozempic/Wegovy) dosing, side effects, costs, and FDA approval status

More importantly, researchers observed a dose-dependent decrease in the proportion of total fat mass relative to total body mass, accompanied by an increase in the proportion of total lean body mass relative to total body mass

Unlike dietary interventions alone, which often result in weight regain, GLP-1 therapy can help maintain weight loss as long as treatment continues

It is important that medication options for these disease states are either cardioprotective or cardioneutral so that the health of the patient is not worsened

M., Farokhnia, M., Farinelli, L